Literature DB >> 10382582

Nutritional regulation of leptin in humans.

R A Coleman1, T S Herrmann.   

Abstract

Although leptin was first discussed as an "adipostat" that regulated food intake in accordance with triglyceride stores, it has become clear that leptin's role is much more complex and that a great many unanswered questions persist. Human studies have not shown that serum leptin concentrations can be changed rapidly by meals. Insulin seems to have a modest but immediate effect in attenuating the morning nadir of serum leptin as well as a greater effect manifested after 4-6 h. These changes in serum leptin, like the decreases that occur with fasting, are not accompanied by corresponding changes in adipose leptin mRNA, suggesting regulation by translational control or changes in the rate of leptin degradation, secretion or clearance. There is convincing evidence that insulin increases leptin synthesis and secretion, probably through an insulin-dependent effect on glucose metabolism. This effect of insulin is possibly mediated by the hexosamine pathway. What adipocytes seem to be communicating to the brain is not how much triglyceride they contain but whether they are currently synthesizing or hydrolysing triglyceride. Confounding many studies is the problem of leptin's diurnal rhythm. Because many studies only measured leptin during its morning nadir or examined the effects of insulin or specific nutrients provided after an overnight fast, important information on regulation may have been lost.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10382582     DOI: 10.1007/s001250051210

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  15 in total

Review 1.  Antiobesity drugs: current and future issues.

Authors:  M Ammar Hatahet; Nikhil V Dhurandhar
Journal:  Curr Diab Rep       Date:  2002-10       Impact factor: 4.810

2.  Independent circadian and sleep/wake regulation of adipokines and glucose in humans.

Authors:  Steven A Shea; Michael F Hilton; Christine Orlova; R Timothy Ayers; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2005-02-01       Impact factor: 5.958

3.  Immunohistochemical demonstration of leptin in pancreatic islets of non-obese diabetic and CD-1 mice: co-localization in glucagon cells and its attenuation at the onset of diabetes.

Authors:  S Reddy; E M Lau; J M Ross
Journal:  J Mol Histol       Date:  2004-06       Impact factor: 2.611

4.  Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia.

Authors:  Donald A McClain; William A Lubas; Robert C Cooksey; Mark Hazel; Glendon J Parker; Dona C Love; John A Hanover
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-22       Impact factor: 11.205

5.  Intralipid/heparin infusion suppresses serum leptin in humans.

Authors:  P Garcia-Lorda; Wendy Nash; Ansley Roche; F-X Pi-Sunyer; B Laferrere
Journal:  Eur J Endocrinol       Date:  2003-06       Impact factor: 6.664

Review 6.  New aspects of the hormone and cytokine response to training.

Authors:  Jürgen M Steinacker; Werner Lormes; Susanne Reissnecker; Yuefei Liu
Journal:  Eur J Appl Physiol       Date:  2003-11-08       Impact factor: 3.078

Review 7.  The role of leptin in the regulation of neuroendocrine function and CNS development.

Authors:  Gwendolyn W Louis; Martin G Myers
Journal:  Rev Endocr Metab Disord       Date:  2007-06       Impact factor: 6.514

8.  Temporal Changes in Plasma Concentration of Leptin, IGF-1, Insulin and Metabolites Under Extended Fasting and Re-Feeding Conditions in Growing Lambs.

Authors:  Ali Kiani
Journal:  Int J Endocrinol Metab       Date:  2012-12-21

9.  Multi-functional roles of chitosan as a potential protective agent against obesity.

Authors:  Ann M Walsh; Torres Sweeney; Bojlul Bahar; John V O'Doherty
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

10.  Caloric restriction decreases orthostatic tolerance independently from 6° head-down bedrest.

Authors:  John P Florian; Friedhelm J Baisch; Martina Heer; James A Pawelczyk
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.